Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $76 | $55 | $60 | $73 |
| % Growth | 36.9% | -7.4% | -18.1% | – |
| Cost of Goods Sold | $41 | $25 | $26 | $23 |
| Gross Profit | $34 | $30 | $33 | $50 |
| % Margin | 45.7% | 53.9% | 55.8% | 68% |
| R&D Expenses | $15 | $23 | $20 | $16 |
| G&A Expenses | $19 | $23 | $25 | $21 |
| SG&A Expenses | $38 | $42 | $49 | $47 |
| Sales & Mktg Exp. | $19 | $20 | $24 | $26 |
| Other Operating Expenses | $21 | -$0 | $4 | -$1 |
| Operating Expenses | $75 | $65 | $73 | $62 |
| Operating Income | -$28 | -$35 | -$40 | -$12 |
| % Margin | -37.3% | -63.9% | -66.5% | -16.8% |
| Other Income/Exp. Net | -$11 | -$4 | -$2 | -$0 |
| Pre-Tax Income | -$39 | -$39 | -$42 | -$13 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | -$55 | -$40 | -$43 | -$14 |
| % Margin | -72.9% | -72.9% | -72.3% | -18.9% |
| EPS | -0.008 | -0.011 | -0.038 | -0.012 |
| % Growth | 21.5% | 71.5% | -213.3% | – |
| EPS Diluted | -0.008 | -0.011 | -0.038 | -0.012 |
| Weighted Avg Shares Out | 4,766 | 3,743 | 1,456 | 1,397 |
| Weighted Avg Shares Out Dil | 4,766 | 3,743 | 1,456 | 1,397 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $4 | $2 | $1 |
| Depreciation & Amortization | $6 | $4 | $4 | $4 |
| EBITDA | -$40 | -$31 | -$35 | -$8 |
| % Margin | -53.5% | -55.7% | -58.9% | -10.7% |